✦ LIBER ✦

Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients

✍ Scribed by Tatsuo Kanda,Toshirou Nishida,Norihito Wada…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN78 OST-EFFECTIVENESS ANALYSIS OF ADJU

✍ I Krysanov; N Zorin; E Pyadushkina; DA Koval 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

9413 Phase II trial of adjuvant imatinib

✍ Nishida, T.; Kanda, T.; Wada, N.; Kobayashi, O.; Yamamoto, M.; Sawaki, A.; Boku, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Adjuvant Imatinib treatment after R0 res

✍ Wei-Zhong Jiang; Guo-Xian Guan; Hui-Shan Lu; Ying-Hong Yang; De-Yong Kang; He-Gu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Re-appraisal of risk classifications for

✍ Yanagimoto, Yoshitomo; Takahashi, Tsuyoshi; Muguruma, Kazuya; Toyokawa, Takahiro 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 555 KB

Phase II study of motesanib in Japanese

✍ Akira Sawaki; Yasuhide Yamada; Yoshito Komatsu; Tatsuo Kanda; Toshihiko Doi; Mas 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 302 KB

Response to imatinib rechallenge in a pa

✍ Yoon-Koo Kang 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 576 KB